Episode Details
Back to Episodes
Dr. Whitehead Joins UBC’s Global Research Push | Canada News
Description
Canada’s pouring $1.7 billion into global science talent, bringing in 64 top researchers—including 9 headed to UBC—aiming to build a powerhouse in AI, cybersecurity, and biotech over 12 years. Dr. Kathryn Whitehead, a lipid nanoparticle pioneer behind mRNA vaccine tech, is among them, leaving Carnegie Mellon for UBC’s world-class labs and access to trailblazers like Pieter Cullis. Her mission? Engineer nanoparticles that target specific organs and tailor treatments for women’s unique biological needs—opening new frontiers in precision medicine and cementing Canada’s rise as a global R&D leader.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/6f2d2d3c677a223d